Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Michael Behnes

Heidelberg, BW, DE 
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Michael Behnes practices in Heidelberg, Germany. Mr. Behnes is rated as an Experienced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Cardiogenic Shock, Ventricular Fibrillation, Heart Failure, Percutaneous Coronary Intervention (PCI), and Atherectomy.

His clinical research consists of co-authoring 309 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Heidelberg, BW, Germany
Other Locations
Salem, BW, Germany
Mannheim, BW 68167, Germany
Manheim, NW, Germany
University Heart And Vascular Center Hamburg And Asklepios Clinic St. Georg, Winnenden And Zentralklinik Bad Berka, Bad Berka, TH, Germany
St. Vincenz Hospital, Karlsruhe, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drugs: Ticagrelor, Prasugrel
Study Phase: Phase 4

309 Total Publications

Coronary Chronic Total Occlusions Affect Long-Term Prognosis in Heart Failure With Mildly Reduced Ejection Fraction.
Coronary Chronic Total Occlusions Affect Long-Term Prognosis in Heart Failure With Mildly Reduced Ejection Fraction.
Journal: Journal of the American Heart Association
Published: August 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Behnes's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 8 Advanced Conditions
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile